top of page
Image by Ivan Aleksic

Diagnostic solutions

Diagnostic Solutions

Our Diagnostic Portfolios

At Genventis Diagnostics, we develop innovative solutions across three key areas: Instrument-Based Diagnostics and CDx, In-Vitro Tests and Assays including CDx, and AI-Powered Digital Diagnostic Solutions. Our integrated approach combines cutting-edge instruments, reliable in-vitro tests, and intelligent digital platforms to deliver accurate, evidence-based insights that empower laboratories, healthcare providers, and patients worldwide.

In-Vitro Tests and Assays

This portfolio encompasses molecular, genomic, and biomarker-based in-vitro diagnostics and companion diagnostics (CDx) designed to detect diseases, monitor progression, and guide therapy selection. Our tests support conditions such as cancer, diabetes, infectious diseases (COVID-19, hepatitis, HPV), and more. Samples, including blood, tissue, and other biological specimens, are analyzed either at physicians’ offices or in laboratories equipped with our instruments. These diagnostics enable early detection, patient stratification, and personalized medicine by delivering reliable, evidence-based insights to guide clinical decisions.

Medical Test Tubes

Some of our tests come in the form of test strips and don’t require any instruments.

Lab Test Tubes

Other tests are developed to be run on instruments and come in a cassette form.

Instrument-Based Diagnostics

Our instrument-based diagnostic and companion diagnostic (CDx) solutions range from compact devices to large laboratory systems. Compact instruments are intended for point-of-care settings, use in clinics and physicians’ offices, where they analyze patient blood or urine to provide timely results. Larger modular systems, designed for central laboratories, can handle hundreds of samples simultaneously, supporting comprehensive molecular testing and enabling accurate detection and monitoring of diseases. These instruments facilitate high-throughput diagnostics and integrate seamlessly with assays to support clinical decision-making

Sample testing

Our laboratory diagnostic systems leverage cutting-edge technologies designed for high precision and reliability. Fully automated, these instruments can process large volumes of samples quickly and efficiently, minimizing human error and ensuring consistent, accurate results. This advanced automation allows laboratories to deliver timely, high-quality data, supporting better patient care and enabling confident clinical decision-making.

Image by Protais Benjamin MUGENZI

High-capacity diagnostic instruments are used in centralized laboratories, supporting batch processing and high-throughput analysis of multiple patient samples

Image by National Cancer Institute

Compact diagnostic instruments are utilized in near-patient settings, such as physician offices, supporting point-of-care testing by processing individual patient samples.

Diagnostic Solutions

Focus areas of diagnostics

Our diagnostic focus areas center on advancing early detection, accurate diagnosis, and biomarker-driven insights to support timely clinical decision-making and improve patient outcomes.

Image by National Cancer Institute

Diagnostics in oncology

Innovative tests and assays for early cancer detection, monitoring disease progression, and guiding personalized treatment strategies to improve patient outcomes.

Read more

Image by Sweet Life

Diabetes care

Providing innovative diagnostic and monitoring solutions to support effective management and personalized care for the over 530 million people affected by diabetes globally, helping clinicians make timely, evidence-based decisions.

Read more

Image by masakazu sasaki

Infectious diseases

Advanced diagnostic testing for viral, bacterial, and other infectious agents. Our solutions enable rapid and accurate detection, continuous patient monitoring, and effective outbreak management to safeguard public health.

Read more

Image by VO2 Master

Diagnostics in cardiometabolic disease

Innovative tools to assess cardiovascular and metabolic health, providing clinicians with actionable insights for early detection, risk stratification, and personalized intervention strategies to reduce disease burden.

Read more

Image by Marek Pavlík

Neurology

Precision diagnostic solutions for neurological and neurodegenerative disorders. Our tools help track disease progression, support early intervention, and inform individualized care plans to enhance patient outcomes.

Read more

Image by Buddha Elemental 3D

Immunology & Rare Diseases

Specialized diagnostics for immune system disorders and rare conditions. These tests empower clinicians to make accurate diagnoses, monitor patient response, and develop tailored care strategies for complex and uncommon diseases.

Read more

AI-powered Digital Diagnostic Solutions

We leverage AI and diagnostic data through an evidence-based approach within an open digital ecosystem, transforming data into actionable insights to support patient care and enhance efficiency in labs and clinics.

Image by Elen Sher

Laboratories

Streamline operations and enhance efficiency with data-driven workflow solutions designed for modern labs.

Image by National Cancer Institute

Healthcare Providers:

Healthcare Providers: Access virtual support and analytics tools to improve diagnostic accuracy, optimize resource use, and guide personalized care.

Image by Jane Korsak

Patients

Patients: Empower self-monitoring and secure access to test results through intuitive, AI-enabled digital platforms.

We strive to contribute and be at the forefront of groundbreaking research for these small, yet collectively large populations, to increase the treatments available within the rare disease space. Our dedicated division, Diagnostic Reach will enable us to achieve this, through several optimized approaches.

100%

Image by Windows

Want the full list of Genventis diagnostics solutions?

Genventis Diagnostics provides advanced IVD and molecular diagnostic solutions focused on early detection, precision medicine, and biomarker-driven care. Its portfolio includes liquid biopsy (blood-based), tissue-based pathology testing, genomic and molecular assays, and companion diagnostics (CDx) supporting oncology and other disease areas. The company also supports clinical trials through assay development, validation, and laboratory operations, delivering high-quality, compliant, and scalable diagnostic solutions.

bottom of page